Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Handling Unplanned Instrument Downtime – V 2.0

Posted on By

Analytical Method Development: SOP for Handling Unplanned Instrument Downtime – V 2.0

Standard Operating Procedure for Managing Unplanned Instrument Downtime in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/351/2025
Supersedes SOP/AMD/351/2022
Page No. Page 1 of 11
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

This SOP defines the systematic approach for handling unplanned instrument downtime in the Analytical Method Development (AMD) laboratory. The objective is to ensure continuity of critical activities, minimize impact on analytical schedules, and maintain GMP compliance

through proper documentation, communication, and risk assessment.

2. Scope

This SOP applies to all major analytical instruments used in AMD such as HPLC, GC, UV, FTIR, dissolution apparatus, and balances. It includes procedures for reporting breakdowns, logging deviations, initiating service, and managing impacted analysis.

3. Responsibilities

  • Analyst: Immediately reports downtime to the Section Head and logs initial observations.
  • Section Head: Coordinates service request, reviews impact, and documents alternative arrangements.
  • QA Representative: Reviews deviation, verifies CAPA implementation, and closes investigation.
  • Engineering/Maintenance: Diagnoses, repairs, and provides instrument service report.
See also  Analytical Method Development: SOP for Spray Droplet Size Distribution Analysis - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring timely resolution of instrument downtime, regulatory reporting (if applicable), and implementation of preventive controls for future mitigation.

5. Procedure

5.1 Initial Identification and Reporting

  1. If an instrument fails to function properly or produces abnormal results (e.g., pressure fluctuations, noise, drift), stop analysis immediately.
  2. Record error message, instrument status, and any prior maintenance activities in the Instrument Downtime Log (Annexure-1).
  3. Inform the Section Head and mark the instrument as “Out of Service” with appropriate signage.

5.2 Impact Assessment

  1. Review pending and ongoing analytical work impacted by the downtime.
  2. Assess whether any batch release, stability study, or validation timelines will be affected.
  3. If applicable, initiate a deviation report (refer SOP/QA/Deviation/2025) and document the risk to data integrity.

5.3 Corrective Action and Service Request

  1. Contact internal engineering team or authorized vendor for immediate troubleshooting and repair.
  2. Record all interactions, service visit logs, replaced components, and downtime duration in Annexure-2.
  3. Only GMP-qualified personnel may conduct service on regulated instruments.
See also  Analytical Method Development: SOP for LOD and LOQ Determination - V 2.0

5.4 Temporary Analytical Arrangements

  1. If critical analysis is pending, request QA approval to use alternative validated instruments of the same make/model.
  2. Ensure method transfer verification, if applicable, is documented.
  3. Record details of interim arrangements in the analytical worksheet and final report.

5.5 Post-Service Qualification

  1. Once repaired, perform verification checks as per instrument-specific SOPs (e.g., calibration, system suitability).
  2. Conduct performance qualification (PQ) if critical hardware or firmware was replaced.
  3. QA must approve requalification before resuming routine use.

5.6 Documentation and Review

  1. Ensure all logs, service records, qualification data, and CAPA are attached to the deviation or breakdown file.
  2. QA must review and sign off all entries.
  3. Trends of recurring issues must be reviewed monthly for preventive maintenance planning.

6. Abbreviations

  • HPLC: High Performance Liquid Chromatography
  • GC: Gas Chromatography
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • PQ: Performance Qualification

7. Documents

  1. Annexure-1: Instrument Downtime Log
  2. Annexure-2: Instrument Service and Repair Record
  3. SOP/QA/Deviation/2025 – Deviation Handling
See also  Analytical Method Development: SOP for Raman Spectroscopy Method Development - V 2.0

8. References

  • 21 CFR Part 211 – GMP for Finished Pharmaceuticals
  • ICH Q9 – Quality Risk Management
  • MHRA and WHO Guidelines on Laboratory Equipment Maintenance

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ritika Sharma Mayur Desai Dr. Nidhi Srivastava
Designation Analyst – AMD QA Reviewer Head – Analytical Method Development
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Instrument Downtime Log

Date Instrument ID Description of Issue Action Taken Status
30/05/2025 HPLC-002 Detector not responding Vendor visit, replaced detector lamp Resolved

Annexure-2: Instrument Service and Repair Record

Instrument ID Service Date Engineer Name Details of Repair Next Calibration Due
HPLC-002 31/05/2025 Rajesh Patil Replaced lamp and recalibrated 31/08/2025

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Updated CAPA process and annexures Annual review Dr. Nidhi Srivastava
01/06/2022 1.0 Initial release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Risk Assessment During Manufacturing – V 2.0
Next Post: Elixir Department: SOP for Documentation Control – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version